IndraLab

Statements


USP37 activates tumorigenicity. 2 / 2
| 2

eidos
"USP37 knockdown inhibits tumorigenicity and increases sensitivity to cisplatin in vivo ."

eidos
"Additionally , USP37 knockdown inhibited tumorigenicity and increased anticancer effect of cisplatin in vivo ."